|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
21
|
|
pubmed:dateCreated |
2010-11-2
|
|
pubmed:abstractText |
To compare clinical, immunohistochemical (IHC), and gene expression models of prognosis applicable to formalin-fixed, paraffin-embedded blocks in a large series of estrogen receptor (ER)-positive breast cancers from patients uniformly treated with adjuvant tamoxifen.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:BernardPhilip SPS,
pubmed-author:CheangMaggie C UMC,
pubmed-author:DaviesSherri RSR,
pubmed-author:EbbertMarkM,
pubmed-author:EllisMatthew JMJ,
pubmed-author:LeungSamuelS,
pubmed-author:MardisElaine RER,
pubmed-author:NielsenTorsten OTO,
pubmed-author:ParkerJoel SJS,
pubmed-author:PerouCharles MCM,
pubmed-author:ReedJerryJ,
pubmed-author:SniderJacquelineJ,
pubmed-author:StijlemanInge JIJ,
pubmed-author:VickeryTammiT,
pubmed-author:VoducDavidD
|
|
pubmed:copyrightInfo |
©2010 AACR.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5222-32
|
|
pubmed:dateRevised |
2011-11-1
|
|
pubmed:meshHeading |
pubmed-meshheading:20837693-Adult,
pubmed-meshheading:20837693-Aged,
pubmed-meshheading:20837693-Aged, 80 and over,
pubmed-meshheading:20837693-Antineoplastic Agents, Hormonal,
pubmed-meshheading:20837693-Breast Neoplasms,
pubmed-meshheading:20837693-Carcinoma,
pubmed-meshheading:20837693-Diagnostic Techniques, Endocrine,
pubmed-meshheading:20837693-Female,
pubmed-meshheading:20837693-Humans,
pubmed-meshheading:20837693-Immunohistochemistry,
pubmed-meshheading:20837693-Middle Aged,
pubmed-meshheading:20837693-Neoplasm Staging,
pubmed-meshheading:20837693-Prognosis,
pubmed-meshheading:20837693-Receptors, Estrogen,
pubmed-meshheading:20837693-Tamoxifen
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.
|
|
pubmed:affiliation |
Genetic Pathology Evaluation Centre, Vancouver Coastal Health Research Institute, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. torsten@interchange.ubc.ca
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Evaluation Studies,
Research Support, N.I.H., Extramural
|
